Ming Zhao

10.0k total citations · 1 hit paper
199 papers, 6.7k citations indexed

About

Ming Zhao is a scholar working on Biotechnology, Biomedical Engineering and Genetics. According to data from OpenAlex, Ming Zhao has authored 199 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Biotechnology, 72 papers in Biomedical Engineering and 61 papers in Genetics. Recurrent topics in Ming Zhao's work include Cancer Research and Treatments (88 papers), Nanoplatforms for cancer theranostics (69 papers) and Virus-based gene therapy research (60 papers). Ming Zhao is often cited by papers focused on Cancer Research and Treatments (88 papers), Nanoplatforms for cancer theranostics (69 papers) and Virus-based gene therapy research (60 papers). Ming Zhao collaborates with scholars based in United States, China and Japan. Ming Zhao's co-authors include Robert M. Hoffman, Michael Bouvet, Meng Yang, Yong Zhang, Sheldon Penman, Huaiyu Ma, Shukuan Li, Peihong Wu, Xiaoming Li and Ning Lyu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ming Zhao

192 papers receiving 6.7k citations

Hit Papers

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, ... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
    2019 372 citations Wei Wei, Ming Zhao et al. profile →

Peers

Ming Zhao
Katsuhiro Hayashi Japan
Paule Opolon France
Veena Kapoor United States
Raffit Hassan United States
Winan J. van Houdt Netherlands
Hans Schreiber United States
I. J. Fidler United States
Michele W.L. Teng Australia
Chiara Castelli Italy
Hiroyoshi Nishikawa Japan
Katsuhiro Hayashi Japan
Ming Zhao
Citations per year, relative to Ming Zhao Ming Zhao (= 1×) peers Katsuhiro Hayashi

Countries citing papers authored by Ming Zhao

Since Specialization
Citations

This map shows the geographic impact of Ming Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhao more than expected).

Fields of papers citing papers by Ming Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhao. The network helps show where Ming Zhao may publish in the future.

Co-authorship network of co-authors of Ming Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Zhao. A scholar is included among the top collaborators of Ming Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Zhao. Ming Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Wen, Fei Wu, Zhongdong Qiao, Ming Zhao, & Haiyang Hu. (2025). Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy. Theranostics. 15(11). 5007–5028. 1 indexed citations
2.
3.
Liang, Youcai, et al.. (2025). Multi-criteria parameter analysis and optimization of a combined cooling, heating, and power system based on SOFC/GT and S-CO2/T-CO2 cycle. Applied Thermal Engineering. 272. 126433–126433. 4 indexed citations
4.
5.
Jaiswal, Sushil Kumar, Hua Tan, Valer Gotea, et al.. (2024). The Megacomplex protects ER-alpha from degradation by Fulvestrant in epithelial ovarian cancer. Cancer Letters. 608. 217129–217129. 2 indexed citations
6.
Liu, Yongxiang, Haijing Deng, Feng Cheng, et al.. (2024). Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma. Nature Communications. 15(1). 1754–1754. 26 indexed citations
7.
Udompholkul, Parima, Carlo Baggio, Luca Gambini, et al.. (2021). Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates. Molecules. 26(12). 3687–3687. 6 indexed citations
8.
Salem, Ahmed F., Luca Gambini, Sandrine Billet, et al.. (2020). Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model. Cancers. 12(10). 2854–2854. 17 indexed citations
9.
Miyake, Kentaro, Takuya Murata, Takashi Murakami, et al.. (2019). Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model. Archives of Gynecology and Obstetrics. 299(6). 1683–1690. 16 indexed citations
10.
Park, Jun Ho, Ming Zhao, Qinghong Han, et al.. (2019). Efficacy of oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil on primary colon cancer in a patient-derived orthotopic xenograft mouse model. Biochemical and Biophysical Research Communications. 518(2). 306–310. 34 indexed citations
11.
Zou, Ru-Hai, Wei Wei, Jing-Xian Shen, et al.. (2018). Comparison of Stable and Unstable Ethiodized Oil Emulsions for Transarterial Chemoembolization of Hepatocellular Carcinoma: Results of a Single-Center Double-Blind Prospective Randomized Controlled Trial. Journal of Vascular and Interventional Radiology. 29(8). 1068–1077.e2. 15 indexed citations
12.
13.
Tian, Rongrong, et al.. (2017). Clinical value of preoperative 18F-FDG PET-CT imaging in staging of colorectal cancer. 29(12). 809–814. 1 indexed citations
14.
Binder, David C., Boris Engels, Ainhoa Arina, et al.. (2013). Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer. Cancer Immunology Research. 1(2). 123–133. 65 indexed citations
15.
Arrach, Nabil, Pui Cheng, Ming Zhao, et al.. (2010). High-Throughput Screening for Salmonella Avirulent Mutants That Retain Targeting of Solid Tumors. Cancer Research. 70(6). 2165–2170. 42 indexed citations
16.
17.
Kishimoto, Hiroyuki, Ming Zhao, Katsuhiro Hayashi, et al.. (2009). In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proceedings of the National Academy of Sciences. 106(34). 14514–14517. 119 indexed citations
18.
Zhang, Liang, Zilin Huang, Peihong Wu, et al.. (2009). Minimally invasive therapy for primary hepatocellular carcinoma with lung metastasis. 15(3). 224–228. 1 indexed citations
19.
Arrach, Nabil, Ming Zhao, Steffen Porwollik, Robert M. Hoffman, & Michael McClelland. (2008). Salmonella Promoters Preferentially Activated Inside Tumors. Cancer Research. 68(12). 4827–4832. 65 indexed citations
20.
Miki, Kenji, Waddah B. Al‐Refaie, Min Xu, et al.. (2000). Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment.. PubMed. 60(10). 2696–702. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuhiro Hayashi Breakdown of academic impact, for papers by Paule Opolon Breakdown of academic impact, for papers by Veena Kapoor Breakdown of academic impact, for papers by Raffit Hassan Breakdown of academic impact, for papers by Winan J. van Houdt Breakdown of academic impact, for papers by Hans Schreiber Breakdown of academic impact, for papers by I. J. Fidler Breakdown of academic impact, for papers by Michele W.L. Teng Breakdown of academic impact, for papers by Chiara Castelli Breakdown of academic impact, for papers by Hiroyoshi Nishikawa
Rankless by CCL
2026